Clinical Trials Directory

Trials / Unknown

UnknownNCT04807023

Decompensation of Cirrhosis and Iron Metabolism

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Iron is a crucial metal whose metabolism is tightly regulated. Iron deficiency or iron overload are both deleterious at the cellular, organic and systemic levels. In line with the major role of the liver in iron homeostasis, links between iron metabolism and acute on chronic liver failure have been highlighted. Nevertheless, due to the difficulty of accurately assessing iron metabolism in this situation, therapeutic intervention on iron metabolism in this setting is currently not codified. A better understanding of these mechanisms is therefore essential, in particular by characterizing the impact of exposure to non-transferrin-bound iron in acute on chronic liver failure on short-term mortality. Overall, a better understanding of the physiopathological mechanisms of iron should allow to optimize the martial balance in this condition and also improve therapeutic approaches.

Conditions

Interventions

TypeNameDescription
BIOLOGICALblood samplingblood sampling

Timeline

Start date
2021-05-17
Primary completion
2022-05-01
Completion
2022-11-01
First posted
2021-03-19
Last updated
2021-07-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04807023. Inclusion in this directory is not an endorsement.